YLPM1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 5.55111512312578E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
7.3914999676461E-09 |
Normal-vs-Stage2 |
7.54990003848377E-09 |
Normal-vs-Stage3 |
<1E-12 |
Normal-vs-Stage4 |
1.62481139653892E-12 |
Stage1-vs-Stage2 |
5.924300E-02 |
Stage1-vs-Stage3 |
8.34600000221286E-09 |
Stage1-vs-Stage4 |
6.73429999986652E-07 |
Stage2-vs-Stage3 |
4.521600E-02 |
Stage2-vs-Stage4 |
5.146400E-02 |
Stage3-vs-Stage4 |
7.746400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62492241884138E-12 |
Normal-vs-AfricanAmerican |
1.48929999999048E-07 |
Normal-vs-Asian |
1.324430E-01 |
Caucasian-vs-AfricanAmerican |
7.067600E-01 |
Caucasian-vs-Asian |
1.473430E-01 |
AfricanAmerican-vs-Asian |
2.851400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
<1E-12 |
Normal-vs-Female |
1.62489999233628E-09 |
Male-vs-Female |
4.897200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.22250000003754E-06 |
Normal-vs-Age(41-60Yrs) |
1.73509984158216E-10 |
Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
Normal-vs-Age(81-100Yrs) |
1.54200000546112E-08 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.322800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.193200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.663200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.427600E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.162500E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.308600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
9.279400E-01 |
Normal-vs-Grade 2 |
2.22480001088599E-09 |
Normal-vs-Grade 3 |
1.62447832963153E-12 |
Normal-vs-Grade 4 |
1.62447832963153E-12 |
Grade 1-vs-Grade 2 |
4.698600E-03 |
Grade 1-vs-Grade 3 |
3.94820000004792E-06 |
Grade 1-vs-Grade 4 |
2.5735999997778E-07 |
Grade 2-vs-Grade 3 |
1.89680999999053E-05 |
Grade 2-vs-Grade 4 |
1.60160000040044E-07 |
Grade 3-vs-Grade 4 |
2.945900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.09309999940521E-08 |
Normal-vs-ccB subtype |
1.63424829224823E-12 |
ccA subtype-vs-ccB subtype |
4.049500E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.66067160023431E-12 |
Normal-vs-N1 |
1.7610000013768E-08 |
N0-vs-N1 |
4.587900E-02 |
|
|